Biocardia Inc (BCDA NASDAQ) stock market data APIs
$0.9461
-0.02(-2.1%)
as of May 22, 2026
Try our APIs with
free plan!
Biocardia Inc Financial Data Overview
Price chart is built with
Anychart
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. It also provides CardiALLO, an allogeneic mesenchymal stem cell therapy which is in phase II for ischemic heart failure; allogeneic cell therapy platform; and PulmALLO, an allogeneic mesenchymal stem cell therapy for acute respiratory distress syndrome. In addition, the company offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; Heart3D for fusion imaging; and morph DNA and avance steerable introducers. It has a license and distribution agreement with Biomet Biologics, LLC. BioCardia, Inc. is based in Sunnyvale, California.
Prev. Close
0.9461
Open
0.9266
High
0.9536
Low
0.9005
52 wk Range
0.84-2.45
Market Cap
10 806 K
Shares Outstanding
11 375 K
EPS
-0.21
Beta
0.551
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Biocardia Inc data using free add-ons & libraries
Get Biocardia Inc Fundamental Data
Biocardia Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -7 803 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-15
- EPS/Forecast: -0.17
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Biocardia Inc News
New
BioCardia outlines Japan Shonin filing in ~7 months and targets ~19-month path to approval for CardiAMP
Earnings Call Insights: BioCardia (BCDA) Q1 2026 MANAGEMENT VIEW * "We have had significant accomplishments this last quarter for our CardiAMP Cell Therapy for the treatment of ischemic heart fail...
BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026
SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
BioCardia Aligns With FDA On Helix Transendocardial Delivery Catheter Marketing Pathways
(RTTNews) - BioCardia Inc. (BCDA), a clinical-stage regenerative medicine company, on Friday announced alignment with the U.S. food and drug administration after a pre-submission meeting on the Helix ...
BioCardia Seeks Accelerated Approval Pathway For CardiAMP In Heart Failure
(RTTNews) - BioCardia Inc. (BCDA) announced it has submitted data from its CardiAMP Heart Failure (HF) clinical study to the U.S. FDA and formally requested a meeting to discuss an accelerated approva...
Get Biocardia Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
